Polygalactosyl sucrose ester acyltransferase gene, protein and its application

By using the PtPSEs gene of phenylpropanoid sucrose ester to catalyze the synthesis of phenylpropanoid sucrose monoester, the problem of the lack of research on the biosynthetic pathway in Polygala tenuifolia medicinal material was solved, and safe and efficient synthesis of phenylpropanoid sucrose ester was achieved.

CN119464243BActive Publication Date: 2026-11-10AGRICULTURAL GENOMICS INSTITUTE AT SHENZHEN CHINESE ACADEMY OF AGRICULTURAL SCIENCES (SHENZHEN BRANCH GUANGDONG LABORATORY FOR LINGNAN MODERN AGRICULTURE)
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411770050.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-12-04
Publication Date
2026-11-10
Estimated Expiration
2044-12-04

AI Technical Summary

Technical Problem

In the existing technology, the biosynthetic pathway of phenylpropanoid sucrose ester in Polygala tenuifolia has not been fully studied, which limits its in-depth development and application.

Method used

We provide the polygalactopropyl sucrose ester acyltransferase gene PtPSEs and its encoded protein, and catalyze the synthesis of phenylpropanol sucrose monoester using sucrose and phenylpropanol acyl-CoA as substrates in 1×PBS buffer.

Benefits of technology

The safe and efficient biosynthesis of phenylpropanoid sucrose ester was achieved. The product is relatively simple, easy to separate and utilize, and has good application value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119464243B_ABST
    Figure CN119464243B_ABST
Patent Text Reader

Abstract

This invention relates to the field of synthetic biology, specifically to the phenylpropanol sucrose ester acyltransferase genes, proteins, and their applications. This invention provides the phenylpropanol sucrose ester acyltransferase genes PtPSE1, PtPSE2, PtPSE3, and PtPSE4, and the proteins encoded by these genes. This invention utilizes the proteins encoded by these genes to regulate the synthesis of phenylpropanol sucrose monoester in PBS buffer, using sucrose and phenylpropanol acyl-CoA as substrates. This catalytic reaction system exhibits high safety, simple substrates, relatively singular products, and ease of subsequent separation and utilization. Therefore, the PtPSE1, PtPSE2, PtPSE3, and PtPSE4 genes and their encoded proteins have good application value and prospects in the biosynthesis of phenylpropanol sucrose monoester.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, and specifically relates to a phenylpropanoid sucrose ester acyltransferase gene from Polygala tenuifolia, the corresponding protein and application thereof. Background Art

[0002] Phenylpropanoid sucrose esters (PSEs) are phenylpropanoid glycoside ester compounds obtained by esterification reaction between the hydroxyl group of sucrose and the carboxyl group of phenylpropanoid phenolic acid, including sucrose ester products modified with 1 phenylpropanoid group, 2 phenylpropanoid groups, 3 phenylpropanoid groups or more phenylpropanoid groups. The phenylpropanoid groups in the phenylpropanoid sucrose esters may consist of different phenylpropanoyl groups, including Benzoyl, p-Hydroxybenzoyl, 4-Methoxybenzoyl, Cinnamoyl, Caffeoyl, Feruloyl, Sinapoyl, 3,4,5-Trimethoxycinnamoyl and the like. PSEs compounds are widely distributed in the medicinal tissues of traditional Chinese medicinal materials, and have a variety of pharmacological activities such as anti-tumor, antibacterial, antioxidant, antiviral, anti-inflammatory, antidepressant, anti-senile dementia, brain neuroprotection and glycosidase inhibition. PSEs compounds have become important precursors for the research and development of safe and effective new drugs, one of the research focuses in the field of traditional Chinese medicine for many years, and have attracted increasing attention from scholars at home and abroad.

[0003] The traditional Chinese medicine Polygalae Radix is the dried root of Polygala tenuifolia Willd. or Polygala sibirica L. (ovate-leaved polygala) belonging to the genus Polygala of the family Polygalaceae. It is mainly distributed in Northeast China, North China, Northwest China, Central China, Sichuan and other regions in China, with abundant resources. It has the effects of calming the mind and benefiting intelligence, harmonizing the heart and kidney, eliminating phlegm and reducing swelling, and is commonly used to treat insomnia and dreaminess, forgetfulness and palpitation, restlessness caused by non-intersection of heart and kidney, unsmooth expectoration, and sores and abscesses. PSEs sugar esters are important indicator components of Polygalae Radix medicinal materials. The 2020 edition of the Pharmacopoeia of the People's Republic of China specifies that the content of 3,6'-disinapoyl sucrose ester (hydroxycinnamoyl sucrose ester) in the Polygalae Radix entry shall be 0.50% or more as the quality evaluation indicator for the medicinal material.

[0004] PSEs compounds belong to plant secondary metabolic phenylpropanoid glycoside products, and their content in plants is usually very low. Chemical synthesis of PSEs and in vitro enzymatic production by lipase have been developed to some extent. However, key enzymes in the in-vivo biosynthetic pathway of PSEs in plants are rarely reported in studies, which severely limits their in-depth development and application. Summary of the Invention

[0005] The purpose of this invention is to propose the Phenylpropanoid Sucrose Esters Transferases (PSEs) gene PtPSEs and its encoded protein, and their application in the biosynthesis of phenylpropanoid sucrose esters. The encoded protein can regulate the synthesis of phenylpropanoid sucrose monoesters sibiricose A5 (3-O-Feruloyl sucrose) or sibiricose A6 (3-O-Sinapyl sucrose) in a safe 1×PBS buffer (0.01 mol / L, pH 7.2-7.4).

[0006] A first aspect of the present invention provides a polygalactopropyl sucrose ester acyltransferase protein, wherein the amino acid sequence of the polygalactopropyl sucrose ester acyltransferase protein comprises any of the following groups of amino acid sequences:

[0007] (a1) The amino acid sequence shown in SEQ ID NO:5, or an amino acid sequence in which one or more amino acids are added, deleted, or replaced and have the same protein activity;

[0008] (a2) The amino acid sequence shown in SEQ ID NO:6, or an amino acid sequence in which one or more amino acids are added, deleted, or replaced and have the same protein activity as shown in SEQ ID NO:6;

[0009] (a3) The amino acid sequence shown in SEQ ID NO:7, or an amino acid sequence in which one or more amino acids are added, deleted, or replaced and have the same protein activity;

[0010] (a4) The amino acid sequence shown in SEQ ID NO:8, or an amino acid sequence in which one or more amino acids are added, deleted, or replaced and have the same protein activity as shown in SEQ ID NO:8.

[0011] A second aspect of the invention provides a gene encoding the aforementioned polygalactopropyl sucrose ester acyltransferase protein.

[0012] Furthermore, the nucleotide sequence of the gene comprises any of the following groups of nucleotide sequences:

[0013] (b1) The nucleotide sequence shown in SEQ ID NO:1, or a nucleotide sequence that is completely complementary to SEQ ID NO:1;

[0014] (b2) The nucleotide sequence shown in SEQ ID NO:2, or a nucleotide sequence that is completely complementary to SEQ ID NO:2;

[0015] (b3) The nucleotide sequence shown in SEQ ID NO:3, or a nucleotide sequence that is completely complementary to SEQ ID NO:3;

[0016] (b4) The nucleotide sequence shown in SEQ ID NO:4, or a nucleotide sequence that is completely complementary to SEQ ID NO:4.

[0017] A third aspect of the present invention provides a recombinant vector containing the gene encoding the polygalactopylacetyl sucrose acyltransferase protein described above.

[0018] A fourth aspect of the present invention provides a recombinant bacterium, wherein the recombinant bacterium is a recombinant bacterium containing the gene encoding the polygalactopropyl sucrose ester acyltransferase protein described above; or a recombinant bacterium containing a recombinant vector of the gene encoding the polygalactopropyl sucrose ester acyltransferase protein described above.

[0019] A fifth aspect of the present invention provides a kit containing the above-mentioned polygalactopropyl sucrose ester acyltransferase protein; or containing the above-mentioned gene encoding the polygalactopropyl sucrose ester acyltransferase protein; or containing the above-mentioned recombinant vector; or containing the above-mentioned recombinant bacteria.

[0020] The sixth aspect of the present invention provides the use of any one of the following in the synthesis of phenylpropanol sucrose ester acyltransferase protein, or gene encoding phenylpropanol sucrose ester acyltransferase protein, or the above-mentioned recombinant vector, or the above-mentioned recombinant bacteria in the synthesis of phenylpropanol sucrose monoester.

[0021] Furthermore, the application requires the addition of a substrate to synthesize phenylpropanoid sucrose monoester, wherein the substrate is sucrose and phenylpropanoid acyl-CoA.

[0022] Furthermore, the phenylpropanoid sucrose monoester is sibiricose A5 or sibiricose A6.

[0023] The seventh aspect of the present invention provides a method for synthesizing phenylpropanoid sucrose monoester, wherein the method uses sucrose as a substrate and, under the action of polygalactosyl sucrose ester acyltransferase protein, phenylpropanoid acyl-CoA is catalyzed to synthesize phenylpropanoid sucrose monoester, wherein the phenylpropanoid sucrose monoester is sibiricose A5 or sibiricose A6.

[0024] The beneficial effects of this invention are as follows: it provides four phenylpropanol sucrose acyltransferase genes (PtPSE1, PtPSE2, PtPSE3, and PtPSE4), the proteins encoded by PtPSEs, and the applications of these proteins in the biosynthesis of phenylpropanol sucrose esters. The application utilizes an enzymatic reaction system using the proteins encoded by PtPSE genes. This system uses only sucrose and phenylpropanol acyl-CoA as substrates and PBS as a buffer to achieve the biosynthesis of phenylpropanol sucrose esters. This system is highly safe, uses simple reaction substrates, produces relatively singular products, and is easy to separate and utilize subsequently. Therefore, the PtPSE genes and their encoded proteins have good application value and prospects in the biosynthesis of phenylpropanol sucrose monoesters. Attached Figure Description

[0025] Figure 1 It is sibiricose A5 (3-O-Feruloyl sucrose).

[0026] Figure 2 It is sibiricose A6 (3-O-Sinapyl sucrose).

[0027] Figure 3 The image shows the PCR results of PtPSE1, PtPSE2, PtPSE3 and PtPSE4 in this invention, with the marker being DL5000.

[0028] Figure 4 This is a schematic diagram of the pCold-PtPSE1 recombinant vector.

[0029] Figure 5 This is a schematic diagram of the pCold-PtPSE2 recombinant vector.

[0030] Figure 6 This is a schematic diagram of the pCold-PtPSE3 recombinant vector.

[0031] Figure 7 This is a schematic diagram of the pCold-PtPSE4 recombinant vector.

[0032] Figure 8 The results show the purification of PtPSE1, PtPSE2, PtPSE3, and PtPSE4 proteins; where L1 is BSA (1 mg / mL); L2 is pCold-TF; L3 is pCold-PtPSE1; L4 is pCold-PtPSE2; L5 is pCold-PtPSE3; and L6 is pCold-PtPSE4.

[0033] Figure 9HPLC results for the formation of phenylpropanoid sucrose monoester from sucrose and Feruloyl-Coenzyme A catalyzed by PtPSE1, PtPSE2, PtPSE3, and PtPSE4, among which... Figure 9 A represents the HPLC results for the formation of phenylpropanoid sucrose monoester sibiricose A5 (3-O-Feruloylsucrose); Figure 9 B represents the HPLC results for the formation of sibiricose A6 (3-O-Sinapyl sucrose).

[0034] Figure 10 Calculation of enzyme kinetic parameters for PtPSE1 product abundance in response to substrate concentration gradient.

[0035] Figure 11 Calculation of enzyme kinetic parameters for PtPSE2 product abundance in response to substrate concentration gradient.

[0036] Figure 12 Calculation of enzyme kinetic parameters for PtPSE3 product abundance in response to substrate concentration gradient.

[0037] Figure 13 Calculation of enzyme kinetic parameters for PtPSE4 product abundance in response to substrate concentration gradient. Detailed Implementation

[0038] This invention provides four polygalactopropyl sucrose ester acyltransferase genes: PtPSE1 (SEQ ID NO:1), PtPSE2 (SEQ ID NO:2), PtPSE3 (SEQ ID NO:3), and PtPSE4 (SEQ ID NO:4).

[0039] This invention provides four proteins encoded by the polygalactopropyl sucrose ester acyltransferase genes, namely the protein encoded by PtPSE1 (SEQ ID NO:5), the protein encoded by PtPSE2 (SEQ ID NO:6), the protein encoded by PtPSE3 (SEQ ID NO:7), and the protein encoded by PtPSE4 (SEQ ID NO:8).

[0040] In some embodiments of the present invention, primer sequences for cloning the above-mentioned polygalactopropyl sucrose ester acyltransferase gene are provided, wherein the primers for cloning the PtPSE1 gene are PtPSE1_F (SEQ ID NO:9) and PtPSE1_R (SEQ ID NO:10), the primers for cloning the PtPSE2 gene are PtPSE2_F (SEQ ID NO:11) and PtPSE2_R (SEQ ID NO:12), the primers for cloning the PtPSE3 gene are PtPSE3_F (SEQ ID NO:13) and PtPSE3_R (SEQ ID NO:14), and the primers for cloning the PtPSE4 gene are PtPSE4_F (SEQ ID NO:15) and PtPSE4_R (SEQ ID NO:16).

[0041] In some embodiments of the present invention, primers for constructing the recombinant expression vector pCold-PtPSEs are provided, wherein the primers for constructing the recombinant expression vector pCold-PtPSE1 are pCold-PtPSE1_F (SEQ ID NO:17) and pCold-PtPSE1_R (SEQ ID NO:18); the primers for constructing the recombinant expression vector pCold-PtPSE2 are pCold-PtPSE2_F (SEQ ID NO:19) and pCold-PtPSE2_R (SEQ ID NO:20); the primers for constructing the recombinant expression vector pCold-PtPSE3 are pCold-PtPSE3_F (SEQ ID NO:21) and pCold-PtPSE3_R (SEQ ID NO:22); and the primers for constructing the recombinant expression vector pCold-PtPSE4 are pCold-PtPSE4_F (SEQ ID NO:23) and pCold-PtPSE4_R (SEQ ID NO:20). NO:24).

[0042] In some embodiments of the present invention, a method for constructing pCold-TF recombinant expression vectors for genes PtPSE1, PtPSE2, PtPSE3, and PtPSE4 is provided. The specific steps are as follows: using the PCR recovery products of PtPSE1, PtPSE2, PtPSE3, and PtPSE4 as templates, amplification is performed using pCold-PtPSEs_F and pCold-PtPSEs_R as primers. The target gene fragment is recovered, and the target gene fragment, pCold-TF digestion product, and homologous recombinase are mixed. The ligation product is transformed into competent E. coli Turbo cells, cultured, and 3-5 clones are randomly selected for sequencing. Single colony strains with correct sequencing are cultured overnight, centrifuged to collect bacterial cells, and plasmids are extracted.

[0043] In some embodiments of the present invention, a method for protein expression of genes PtPSE1, PtPSE2, PtPSE3 and PtPSE4 is provided, the specific steps of which are as follows: the recombinant plasmids pCold-PtPSE1, pCold-PtPSE2, pCold-PtPSE3 and pCold-PtPSE4 are transformed into E. coli BL21(DE3) competent cells, recombinant single clones are selected, suitable induction expression conditions are selected, and large-scale expression and protein purification are carried out.

[0044] In some embodiments of the present invention, the application of proteins encoded by the polygalactosyl phenylpropanol sucrose acyltransferase gene PtPSEs in regulating the synthesis of phenylpropanol sucrose esters is provided. This application utilizes the enzymatic reaction of the PtPSEs protein to achieve the synthesis of phenylpropanol sucrose monoesters with specific substrates.

[0045] Furthermore, the aforementioned specific substrate uses sucrose as the acceptor substrate and phenylpropionyl-CoA as the donor substrate.

[0046] In some embodiments of the present invention, a method is provided for regulating the synthesis of phenylpropanoid sucrose esters using proteins encoded by the polygalactopropyl sucrose ester acyltransferase genes PtPSE1, PtPSE2, PtPSE3, and PtPSE4. The specific steps of the method are as follows: PtPSEs proteins are added to 1×PBS buffer (0.01 mol / L, pH 7.2-7.4), followed by Feruloyl-Coenzyme A or Sinapyl-Coenzyme A. Sucrose is added, and the reaction is allowed to proceed for a period of time. Then, methanol is added to terminate the reaction. After centrifugation, the supernatant is filtered through an organic filter membrane to obtain phenylpropanoid sucrose monoesters sibiricose A5 (3-O-Feruloyl sucrose) or sibiricose A6 (3-O-Sinapyl sucrose).

[0047] Terminology Explanation:

[0048] In this invention, "sibiricose A5" refers to 3-O-Feruloyl sucrose; "sibiricose A6" refers to 3-O-Sinapyl sucrose.

[0049] In this invention, the “PtPSEs gene” is selected from one or more of the following: PtPSE1 gene (SEQ ID NO:1), PtPSE2 gene (SEQ ID NO:2), PtPSE3 gene (SEQ ID NO:3) and PtPSE4 gene (SEQ ID NO:4).

[0050] In this invention, “protein expressed by PtPSEs”, “protein encoded by PtPSEs” or “PtPSEs protein” is selected from one or more of the following: protein encoded by the PtPSE1 gene (SEQ ID NO:5), protein encoded by the PtPSE2 gene (SEQ ID NO:6), protein encoded by the PtPSE3 gene (SEQ ID NO:7), and protein encoded by the PtPSE4 gene (SEQ ID NO:8).

[0051] The technical solution of the present invention will be clearly and completely described below with reference to embodiments. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. All embodiments were carried out under conventional experimental conditions or conditions recommended in the manufacturer's instructions. Unless otherwise defined, all technical terms used in this invention have the same meaning as commonly understood by those skilled in the art. Furthermore, any methods and materials similar to or identical to those described can be used in the methods of the present invention. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without inventive effort are within the scope of protection of the present invention.

[0052] Unless otherwise specified, the experimental methods used in the following examples shall be performed according to conventional methods or the manufacturer's recommendations. Unless otherwise specified, all materials, reagents, and consumables used are commercially available.

[0053] Example 1: Cloning of the PtPSEs gene

[0054] Gene cloning method: Using Polygala tenuifolia root cDNA as a template, PCR amplification was performed using cloning primers for genes PtPSE1, PtPSE2, PtPSE3, and PtPSE4, respectively. The gene cloning primer sequences used in this example are shown in Table 1. The PCR reaction system was 30 μL, including 1 μL of cDNA template, 1.5 μL each of F and R primers. Max DNA Polymerase (Takara, R047A) 15 μL, ddH2O 11 μL.

[0055] Set the PCR program as follows: 98℃, 3 min; 98℃, 10 sec, 60℃, 15 sec, 72℃, 60 sec, 35 cycles; 72℃, 8 min, store at 16℃.

[0056] After PCR, gene fragments were detected by 1% agarose gel electrophoresis (e.g., Figure 3 As shown in the figure, the target band of the gene was recovered using an agarose gel extraction kit.

[0057] Table 1. Primer sequence information for gene cloning

[0058]

[0059] Example 2: Construction of PtPSEs gene expression vector

[0060] 1. Obtain PCR fragments:

[0061] Using the recovered PCR products from gene cloning as templates, PCR amplification was performed using homologous recombination primers for genes pCold-PtPSE1, pCold-PtPSE2, pCold-PtPSE3, and pCold-PtPSE4, respectively. The sequences of the homologous recombination primers used in this example are shown in Table 2. The PCR reaction system consisted of 30 μL of PCR product, 1.5 μL each of F and R primers. Max DNA Polymerase (Takara, R047A) 15 μL, ddH2O 11 μL.

[0062] Set the PCR program as follows: 98℃, 2 min; 98℃, 10 sec, 61℃, 15 sec, 72℃, 30 sec, 35 cycles; 72℃, 8 min, 16℃ for storage.

[0063] After PCR, gene fragments were detected by 1% agarose gel electrophoresis, and the target band of the gene was recovered using an agarose gel recovery kit.

[0064] Table 2 shows the homologous recombination primer sequence information for pCold-PtPSEs.

[0065]

[0066] 2. Connection and Recombination:

[0067] The target gene band was recovered using an agarose gel extraction kit. After determining the concentration, the gene fragment was ligated into the cloning vector pCold-TFVector (with Sal I and Kpn I restriction sites). The ligation reaction volume was 10 μL, including 2 μL of homologous recombination PCR product, 3 μL of pCold-TF double enzyme digestion gel recovery product, and 5 μL of 2×ClonExpress Mix. After adding the reaction mixture, the ligation was performed in a PCR instrument at 50℃ for 25 min.

[0068] 3. Transformation:

[0069] 1) Add the ligation product to 100 μL of freshly thawed E. coli Turbo competent cells, then gently mix with a pipette tip and incubate on ice for 30 min.

[0070] 2) After the ice bath is complete, place it in a 42°C water bath for 90 seconds for heat shock, and then immediately put it in an ice bath for 2 minutes.

[0071] 3) Add 900 μL of antibiotic-free LB liquid medium, place on a shaker at 37°C, and incubate at 220 rpm for 1 h.

[0072] 4) Centrifuge at 6000 rpm for 3 min, discard part of the supernatant, and mix the remaining 200 μL with a pipette. Spread the bacterial culture evenly on an LB agar plate (containing 100 mg / L Amp) using a spreader, and invert the plate to incubate overnight at 37°C.

[0073] 5) Randomly select single-clone bacteria for sequencing. Obtain correctly sequenced single-clone colonies carrying the PtPSEs gene, culture them overnight, collect the bacterial cells by centrifugation, and extract the plasmid. A schematic diagram of the PtPSEs gene vector is shown below. Figures 4-7 As shown.

[0074] 4. Identification of the PtPSEs gene expression vector and its gene sequence:

[0075] The sequences of PtPSE1, PtPSE2, PtPSE3, and PtPSE4 were identified and obtained through sequencing. The sequence of PtPSE1 is shown in SEQ ID NO.1; the sequence of PtPSE2 is shown in SEQ ID NO.2; the sequence of PtPSE3 is shown in SEQ ID NO.3; and the sequence of PtPSE4 is shown in SEQ ID NO.4.

[0076] Example 3: Protein expression of PtPSEs gene

[0077] 1. pCold-PtPSEs plasmid was transformed into E. coli BL21(DE3) competent cells:

[0078] 1) Take 100 μL of E. coli BL21(DE3) competent cells melted on ice and add 5 μL of the extracted plasmid. Mix gently and place in an ice bath for 30 min.

[0079] 2) Heat shock in a 42℃ water bath for 60 seconds, then quickly transfer the tube to an ice bath for 2 minutes. Do not shake the centrifuge tube during this process.

[0080] 3) Add 900 μL of sterile LB medium (antibiotic-free) to the centrifuge tube, mix well, and incubate at 37°C and 200 rpm for 90 min to revive the cells.

[0081] 4) Add 200 μL of the transformed competent cells to LB agar medium containing ampicillin (100 μg / ml) and spread the cells evenly. Incubate the plate at 37°C until the liquid is absorbed, then invert the plate and incubate overnight at 37°C.

[0082] 2. Induction of expression and protein purification:

[0083] 1) Pick a single colony containing the recombinant plasmid from the plate and inoculate it into 5 mL (15 mL sterile centrifuge tube) of LB medium containing ampicillin (100 ug / ml) and incubate overnight at 37°C.

[0084] 2) The next day, take 4 mL of culture medium and expand it in 400 mL LB (1 L Erlenmeyer flask) (1% inoculation ratio). Incubate at 37℃ with shaking until OD600 = 0.6-0.8. Immediately transfer the bacterial solution to 15℃ and incubate with shaking at 180 rpm for 30 min. Add IPTG to the bacterial solution to a final concentration of 0.3 mM and continue to incubate at 15℃ with shaking at 180 rpm.

[0085] 3) After overnight induction of expression at 15℃ with shaking, the bacterial cells were collected by centrifugation. 10 mL / g binding buffer (20 mM hosphate buffer, 500 mM NaCl, 10 mM imidazole, pH 7.4) was added, and the cells were sonicated at 45% power for 5 seconds, with 5-second intervals, for a total of 60 min. After centrifugation at 13000 rpm at low temperature, the supernatant was collected, and protein purification began. The specific steps were modified from HisSep Ni-NTA Agarose Resin (Catalog#:20502ES50, YEASEN, China) as follows:

[0086] 4) Agarose Resin pretreatment: Wash agarose 3 times with Binding Buffer, centrifuge at 12000 rpm and discard the supernatant.

[0087] 5) Add the pretreated agarose to the crude protein sample collected after high-speed low-temperature centrifugation, and place it on a 4°C rotary mixer for 12 hours.

[0088] 6) Add the sample to the affinity chromatography column and allow the waste liquid to flow out automatically by gravity. Agarose and binding proteins are retained. Wash the agarose and binding proteins three times with Washing Buffer (20mM Phosphate Buffer, 500mM NaCl, 30mM Imidazole, pH 7.4).

[0089] 7) Finally, elute the target protein with 10 mL of Elution Buffer (20 mM Phosphate Buffer, 500 mM NaCl, 400 mM Midazole, pH 7.4) and collect the eluent as the target protein sample.

[0090] 3. Concentration and impurity removal:

[0091] The purified protein sample was placed into a 100 kDa ultrafiltration tube (Millipore), and an appropriate volume of protein concentration buffer (Tris 50 mM, NaCl 300 mM, pH 7.3) was added. The sample was centrifuged at 1500 rpm for 30 min at low temperature. The filtrate was discarded, and an appropriate volume of protein concentration buffer was added again for centrifugation to concentrate the protein. This process was repeated three times until the protein reached the appropriate concentration.

[0092] 4. Protein identification:

[0093] The retained final protein sample was aliquoted and quantitatively analyzed using the BCA method. Further analysis (10 μl loaded) was performed using 10% SDS-PAGE to detect protein purification and expression. Figure 8 As shown.

[0094] 5. Obtain the proteins expressed by PtPSEs:

[0095] By comparing with the marker and the empty vector, the proteins expressed by PtPSE1, PtPSE2, PtPSE3, and PtPSE4 were obtained. The sequences of PtPSE1, PtPSE2, PtPSE3, and PtPSE4 are shown in SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8, respectively.

[0096] Example 4: PtPSEs protein regulates the synthesis of sucrose monoesters (phenylpropanoid sucrose monoesters)

[0097] In this embodiment, the regulatory role of PtPSEs proteins in the synthesis of phenylpropanoid sucrose monoesters (sibiricose A5 and sibiricose A6) was investigated.

[0098] This example uses a 200 μL reaction system. PtPSEs protein (200 μg) was reacted with 10 mM sucrose as the acceptor substrate and 100 μM Feruloyl-Coenzyme A or Sinapyl-Coenzyme A as the donor substrate in 1×PBS buffer (0.01 mol / L, pH 7.2-7.4). The reaction was carried out at a suitable temperature for a period of time. In this example, the reaction temperature was 30°C for 4 hours; other suitable temperature conditions and reaction times can be used in other examples. The reaction was terminated by adding an equal volume of methanol, impurities were removed by centrifugation, and the final product was obtained by filtration through an organic filter membrane.

[0099] Analysis of the HPLC chromatograms of the products revealed that, compared with the control group (pCold-TF), PtPSEs proteins all produced a distinct peak sibiricoseA5 (…). Figure 9 A) and sibiricose A6 ( Figure 9 B). This indicates that the PtPSEs protein successfully catalyzed the synthesis of phenylpropanoid sucrose monoester in the reaction system, yielding phenylpropanoid sucrose monoester sibiricose A5 (3-O-Feruloyl sucrose). Figure 1 ) and sibiricoseA6(3-O-Sinapyl sucrose)( Figure 2 ).

[0100] Example 5: Kinetic parameters of PtPSEs enzymes

[0101] In this embodiment, a series of substrate concentration gradient experiments were designed to determine the enzyme kinetic parameters of four PtPSEs enzyme proteins with feruloyl-CoA and sinapoyl-CoA. The reaction system included different concentrations of feruloyl-CoA or sinapoyl-CoA substrates (10 μM, 25 μM, 50 μM, 100 μM, 200 μM, 400 μM, 600 μM), 10 mM sucrose, and an enzyme concentration of 1 μg / μL. The reaction was carried out in 1×PBS buffer (pH 7.2-7.4) to ensure the reaction was in the initial induction phase. The reaction conditions were controlled at 30°C, and the reaction volume was 200 μL. By nonlinearly fitting the Michaelis-Mann equation, the maximum reaction rate Vmax, Michaelis constant Km, and catalytic efficiency Kcat of the enzyme were calculated. Furthermore, the catalytic efficiency Kcat / Km of the enzyme at low substrate concentrations was calculated to evaluate catalytic efficiency and substrate specificity.

[0102] The results are as follows Figures 10-13 As shown in Table 3, Pt3G0003260 (named PtPSE1) exhibits the highest maximum reaction rate and the lowest Michaelis constant with respect to feruloyl-CoA, demonstrating the highest catalytic efficiency. In contrast, Pt4G0013510 and Pt9G0004120 (named PtPSE2 and PtPSE3, respectively) show similar kinetic parameters for feruloyl-CoA and sinapicoyl-CoA, although PtPSE2's maximum reaction rate for both substrates is an order of magnitude higher than that of PtPSE3. Compared to other PtPSEs, Pt3G0017700 (named PtPSE4) exhibits the lowest maximum reaction rate for both feruloyl-CoA and sinapicoyl-CoA.

[0103] In summary, PtPSE1 exhibits the highest specificity and catalytic activity towards feruloyl-CoA. These results provide important reference for further optimization and selection of enzymes for the biosynthesis of phenylpropanoid metabolites.

[0104] Table 3 Determination of PtPSEs enzyme kinetic constants

[0105]

[0106] As can be seen from the above examples, the entire phenylpropanoid sucrose monoester biocatalytic reaction was carried out in 1×PBS buffer (0.01 mol / L, pH 7.2-7.4). Apart from sucrose, phenylpropanoid acyl-COA, and the catalyzed PtPSEs protein, no other substances were added. Compared with most previous sucrose ester synthesis methods that required toxic reagents for substrates or solvents, this catalytic reaction system is highly safe, uses simple reaction substrates, and produces relatively singular products—all of which are phenylpropanoid sucrose esters, facilitating subsequent separation and utilization. Therefore, the PtPSEs gene and its protein have good application value and prospects in the biosynthesis of phenylpropanoid sucrose esters.

[0107] It should be noted that the specific parameters or reagents in the above embodiments are specific or preferred embodiments under the concept of the present invention, and not limitations thereof; those skilled in the art can make adaptive adjustments within the concept and protection scope of the present invention.

Claims

1. A polygalactopropyl sucrose ester acyltransferase protein, characterized in that, The amino acid sequence of the polygalactopropyl sucrose ester acyltransferase protein is the amino acid sequence shown in SEQ ID NO:

6.

2. The gene encoding the polygalactopropyl sucrose ester acyltransferase protein as described in claim 1.

3. The gene according to claim 2, characterized in that, The nucleotide sequence of the gene is the nucleotide sequence shown in SEQ ID NO:

2.

4. A recombinant vector, characterized in that, The recombinant vector is a recombinant vector containing the gene described in claim 2 or 3.

5. A recombinant bacterium, characterized in that, The recombinant bacteria are recombinant bacteria containing the gene of claim 2 or 3 or the recombinant vector of claim 4.

6. A reagent kit, characterized in that, It includes the polygalactopropyl sucrose ester acyltransferase protein of claim 1, the gene of claim 2 or 3, the recombinant vector of claim 4, or the recombinant bacteria of claim 5.

7. The use of any one of the following in the synthesis of phenylpropanol sucrose acyltransferase protein as described in claim 1, the gene as described in claim 2 or 3, the recombinant vector as described in claim 4, or the recombinant bacteria as described in claim 5 in the synthesis of phenylpropanol sucrose monoester 3'-O-Feruloyl sucrose or 3'-O-Sinapoyl sucrose; when the substrate is sucrose and feruloyl-CoA, the synthesized product is 3'-O-Feruloyl sucrose; when the substrate is sucrose and sinigloyl-CoA, the synthesized product is 3'-O-Sinapoyl sucrose.

8. A method for synthesizing phenylpropanoid sucrose monoester, characterized in that, Using sucrose as the acceptor substrate, and under the action of the polygalactopropyl sucrose ester acyltransferase protein as described in claim 1, 3'-O-Feruloyl sucrose is synthesized with feruloyl-CoA as the donor substrate, or 3'-O-Sinapoyl sucrose is synthesized with sinigloyl-CoA as the donor substrate.

Citation Information

Patent Citations

  • Nicotinylglycosyltransferase gene NtASAT2 and its encoded protein and application

    CN110872592A